01—Abstract
Summary
Summary of the 10-K filed February 28, 2025. Cited figures are marked; the original filing is the authoritative source.
Axon Enterprise, Inc. (AXON) reported a strong year of revenue growth, with net sales reaching $2.1 billiona, a 33.4% increase compared to the prior year.
This growth was driven by robust demand across both its TASER and Software and Sensors segments, with particular strength in TASER devices (especially the new TASER 10) and Axon Evidence cloud services. The company experienced a significant increase in stock-based compensation expenses, which impacted gross margins, but adjusted gross margins improved due to a higher mix of high-margin cloud services and cost-optimization initiatives. Despite a notable increase in operating expenses, primarily related to salaries, benefits, and stock-based compensation, Axon reported a substantial net income of $377.0 millionb, bolstered by gains on strategic investments.
The company also announced a planned reorganization of its reporting segments into "Connected Devices" and "Software & Services" to better reflect its evolving business structure. However, the report disclosed a material weakness in internal controls related to revenue recognition, which management is actively addressing. From an investor perspective, the continued strong top-line growth is a positive indicator, showcasing the sustained demand for Axon's integrated public safety solutions.
The strategic acquisitions of Fusus and Dedrone in 2024 demonstrate the company's commitment to expanding its ecosystem and technological capabilities. Investors should monitor the progress of the material weakness remediation and the impact of increasing stock-based compensation on profitability. The company's robust cash flow from operations and significant cash and investment balances provide a solid foundation for future growth and strategic investments, while the ongoing expansion into international markets presents further growth opportunities.
02—Key points
Key Highlights
- Axon Enterprise Inc. achieved robust net sales of $2.1 billion, representing a 33.4% increase year-over-year.
- Both the TASER and Software and Sensors segments demonstrated strong growth, with notable contributions from the TASER 10 device and Axon Evidence cloud services.
- Net income rose significantly to $377.0 million, partly due to gains from strategic investments.
- Operating expenses increased, driven by higher stock-based compensation, salaries, and benefits, impacting operating income.
- The company is undergoing a planned segment reorganization into "Connected Devices" and "Software & Services" for clearer reporting.
- A material weakness in internal controls regarding revenue recognition was disclosed, with remediation plans in progress.
- Axon completed strategic acquisitions of Fusus and Dedrone in 2024, expanding its technological capabilities and market reach.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2024, Axon Enterprise, Inc. kept $0.18.
- Revenue$2.08B100.0%
- Cost of revenue−$841.1M40.4%
- Gross profit$1.24B59.6%
- Operating costs−$1.18B56.8%
- Operating income$58.5M2.8%
- Interest, other & tax$318.5M15.3%
- Net income$377.0M18.1%
Where FY2024 revenue went
$2.08B- Cost of revenue: $841.1M, 40% of revenue
- SG&A: $741.2M, 36% of revenue
- R&D: $441.6M, 21% of revenue
- Operating income: $58.5M, 2.8% of revenue
Kept 2.8% as operating incomeOperating income $58.5M · 2.8%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2024filed February 28, 2025Financial Statements
FY2024 against FY2023
| Line item | FY2024FY2023 | Change |
|---|---|---|
| Revenue | $2.08B$1.56B | +33.4% |
| Cost of Revenue | $841.15M$605.25M | +39.0% |
| Gross Profit | $1.24B$955.45M | +29.9% |
| R&D Expenses | $441.59M$303.72M | +45.4% |
| SG&A Expenses | $741.25M$494.88M | +49.8% |
| Operating Expenses | $1.18B$798.60M | +48.1% |
| Operating Income | $58.54M$156.85M | −62.7% |
| Net Income | $377.03M$175.78M | +114.5% |
| EPS (Basic) | $4.98$2.37 | +110.1% |
| EPS (Diluted) | $4.80$2.33 | +106.0% |
| Shares Outstanding (Basic) | 75.75M74.19M | +2.1% |
| Shares Outstanding (Diluted) | 78.56M75.46M | +4.1% |
05—Questions
Frequently Asked Questions
What were the main drivers of Axon's revenue growth in the past fiscal year?
Axon's revenue growth was primarily driven by strong demand across its product lines, including TASER devices, particularly the newer TASER 10, and its cloud-based Axon Evidence software and services. Increased unit sales of Axon body cameras and accessories also contributed significantly.
What is the company's outlook for future growth and profitability?
Axon's strategy focuses on building highly recurring, profitable businesses through continuous product innovation. The company aims to expand its integrated public safety operating system globally, with ongoing investments in R&D and strategic acquisitions. While growth is strong, investors should note the impact of increased stock-based compensation on margins and the ongoing remediation of a material weakness in internal controls.
What are the key risks or challenges facing Axon Enterprise, Inc. as highlighted in the filing?
Key risks include dependence on law enforcement agency acceptance of its products, potential negative publicity, risks associated with rapid technological change and competition, cybersecurity threats, supply chain disruptions, and the potential impact of regulatory changes. The company also disclosed a material weakness in internal controls related to revenue recognition.
06—Continue